# Elicio Therapeutics, Inc.: Form DEF 14A, filed Sep 27, 2024

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: DEF 14A
- Filed: 2024-09-27
- Accepted by EDGAR: Sep 27, 2024, 16:41 ET
- Period: 2024-11-07
- Accession: 0001140361-24-042209
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000114036124042209/ny20035898x2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000114036124042209/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000114036124042209/ny20035898x2_def14a.htm

Filed Sep 27, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-042209. Last ingested by Listed: Nov 5, 2026, 17:56 ET. No prices; not investment advice.